[HTML][HTML] Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies
CL Grandjean, F Montalvao, S Celli, D Michonneau… - Scientific Reports, 2016 - nature.com
Anti-CD20 monoclonal antibodies (mAbs) represent an effective treatment for a number of B
cell malignancies and autoimmune disorders. Glycoengineering of anti-CD20mAb may …
cell malignancies and autoimmune disorders. Glycoengineering of anti-CD20mAb may …
Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies
CL Grandjean, F Montalvao, S Celli… - Scientific …, 2016 - pubmed.ncbi.nlm.nih.gov
Anti-CD20 monoclonal antibodies (mAbs) represent an effective treatment for a number of B
cell malignancies and autoimmune disorders. Glycoengineering of anti-CD20mAb may …
cell malignancies and autoimmune disorders. Glycoengineering of anti-CD20mAb may …
[PDF][PDF] Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies
CL Grandjean, F Montalvao, S Celli, D Michonneau… - cyberleninka.org
Methods Liver transplant. Orthotopic liver transplantation was adapted from Kamada et al.
12 and performed under a microdissecting microscope. To prepare mouse donor livers …
12 and performed under a microdissecting microscope. To prepare mouse donor livers …
Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies
CL Grandjean, F Montalvao, S Celli… - Scientific …, 2016 - ui.adsabs.harvard.edu
Anti-CD20 monoclonal antibodies (mAbs) represent an effective treatment for a number of B
cell malignancies and autoimmune disorders. Glycoengineering of anti-CD20mAb may …
cell malignancies and autoimmune disorders. Glycoengineering of anti-CD20mAb may …
[HTML][HTML] Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies
CL Grandjean, F Montalvao, S Celli… - Scientific …, 2016 - ncbi.nlm.nih.gov
Anti-CD20 monoclonal antibodies (mAbs) represent an effective treatment for a number of B
cell malignancies and autoimmune disorders. Glycoengineering of anti-CD20mAb may …
cell malignancies and autoimmune disorders. Glycoengineering of anti-CD20mAb may …
Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies.
CL Grandjean, F Montalvao, S Celli… - Scientific …, 2016 - europepmc.org
Anti-CD20 monoclonal antibodies (mAbs) represent an effective treatment for a number of B
cell malignancies and autoimmune disorders. Glycoengineering of anti-CD20mAb may …
cell malignancies and autoimmune disorders. Glycoengineering of anti-CD20mAb may …
Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies
CL Grandjean, F Montalvao, S Celli, D Michonneau… - Scientific Reports, 2016 - hal.science
Anti-CD20 monoclonal antibodies (mAbs) represent an effective treatment for a number of B
cell malignancies and autoimmune disorders. Glycoengineering of anti-CD20mAb may …
cell malignancies and autoimmune disorders. Glycoengineering of anti-CD20mAb may …
Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies
CL Grandjean, F Montalvao, S Celli… - Scientific …, 2016 - pasteur.hal.science
Anti-CD20 monoclonal antibodies (mAbs) represent an effective treatment for a number of B
cell malignancies and autoimmune disorders. Glycoengineering of anti-CD20mAb may …
cell malignancies and autoimmune disorders. Glycoengineering of anti-CD20mAb may …
Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies.
CL Grandjean, F Montalvao, S Celli… - Scientific …, 2016 - europepmc.org
Anti-CD20 monoclonal antibodies (mAbs) represent an effective treatment for a number of B
cell malignancies and autoimmune disorders. Glycoengineering of anti-CD20mAb may …
cell malignancies and autoimmune disorders. Glycoengineering of anti-CD20mAb may …